ASX Share rice
Mon 17 May 2021 - 04:17:am (Sydney)

BGT Share Price


BGT Company Information


Bio-Gene Technology Limited





GIC Industry:


GIC Sub Industry:

Fertilizers & Agricultural Chemicals


456 Lonsdale Street Melbourne VIC Australia 3000


61 3 9068 1062

MD, CEO & Director:

Mr. Richard Jagger B.Sc., BSC (HONS), M.INTL.BUS, GAICD

CFO & Company Sec.:

Mr. Roger McPherson C.P.A., CPA, B.Bus, GAICD

Exec. Director of R&D and Exec. Director:

Mr. Peter Donald May AFAIM, M.B.A., MBA, AFA1M, GAICD

Company Overview:

Bio-Gene Technology Limited, a biotechnology company, engages in developing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. It is involved in developing Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from the leaves of rare eucalyptus trees. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has collaborations with Pacific Discovery Services for studying Flavocide's mode of action; and the Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

BGT Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


BGT CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


BGT Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Total Revenue:


BGT Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities (Other):


Non Current Liabilities Total:


BGT Share Price History

BGT News

23 Feb, 2021
We feel now is a pretty good time to analyse Bio-Gene Technology Limited's ( ASX:BGT ) business as it appears the...
25 Nov, 2020
Richard Jagger has been the CEO of Bio-Gene Technology Limited (ASX:BGT) since 2018, and this article will examine the...